BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30807862)

  • 1. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders.
    Sipahi Calis A; Colakoglu Z; Gunbay S
    J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):322-325. PubMed ID: 30807862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism.
    Hosgor H; Altindis S; Sen E
    J Orofac Orthop; 2024 May; 85(Suppl 1):102-108. PubMed ID: 37843582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
    Li K; Tan K; Yacovelli A; Bi WG
    J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Duration of splint therapy in patients with temporomandibular joint disorders].
    Losev FF; Starikov NA; Babunashvili GB; Rudakov AM; Vataeva AA
    Stomatologiia (Mosk); 2023; 102(6. Vyp. 2):37-43. PubMed ID: 38096393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Kim SR; Chang M; Kim AH; Kim ST
    Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.
    Yoshida K
    Toxins (Basel); 2018 Apr; 10(5):. PubMed ID: 29693593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of botulinum toxin A in pain perception and condyle-fossa relationship after the management of temporomandibular dysfunction: a randomized controlled clinical trial.
    Ayala JC; Rizzatti-Barbosa CM; Custodio W
    Oral Maxillofac Surg; 2024 Mar; 28(1):269-277. PubMed ID: 36729315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis.
    Saini RS; Ali Abdullah Almoyad M; Binduhayyim RIH; Quadri SA; Gurumurthy V; Bavabeedu SS; Kuruniyan MS; Naseef PP; Mosaddad SA; Heboyan A
    PLoS One; 2024; 19(3):e0300157. PubMed ID: 38483856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an Interdisciplinary Approach in the Management of Temporomandibular Disorders: A Scoping Review.
    Brighenti N; Battaglino A; Sinatti P; Abuín-Porras V; Sánchez Romero EA; Pedersini P; Villafañe JH
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: A prospective study.
    Ferreira EF; Camões-Barbosa A
    J Stomatol Oral Maxillofac Surg; 2024 Feb; ():101804. PubMed ID: 38412921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.
    Ataran R; Bahramian A; Jamali Z; Pishahang V; Sadeghi Barzegani H; Sarbakhsh P; Yazdani J
    J Dent (Shiraz); 2017 Sep; 18(3):157-164. PubMed ID: 29034269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in the treatment of muscle specific Oro-facial pain: a literature review.
    Sunil Dutt C; Ramnani P; Thakur D; Pandit M
    J Maxillofac Oral Surg; 2015 Jun; 14(2):171-5. PubMed ID: 26028831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral splint for temporomandibular joint disorders with revolutionary fluid system.
    Srivastava R; Jyoti B; Devi P
    Dent Res J (Isfahan); 2013 May; 10(3):307-13. PubMed ID: 24019797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with botulinum toxin of masseter hypertrophy, myalgia of the tendons and attrition induced by bruxism].
    Brand Kanters ART; Steenen SA; Gilden J; Khan M
    Ned Tijdschr Tandheelkd; 2023 Dec; 130(12):525-529. PubMed ID: 38051087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stabilization splints on the signs and symptoms of temporomandibular disorders of muscular origin: A systematic review.
    Honnef LR; Pauletto P; Conti Réus J; Massignan C; Souza BDM; Michelotti A; Flores-Mir C; De Luca Canto G
    Cranio; 2022 Mar; ():1-12. PubMed ID: 35311479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-guided intraoral botulinum toxin injection into the lateral pterygoid muscle for chronic temporomandibular joint dislocation.
    Lee ST; Kim D; Park JH; Kwon TG
    J Korean Assoc Oral Maxillofac Surg; 2024 Feb; 50(1):41-48. PubMed ID: 38419520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of botulinum toxin treatment outcomes of a patient with persistent myofascial orofacial pain.
    Sitnikova V; Kämppi A; Teronen O; Kemppainen P
    Clin Case Rep; 2021 Sep; 9(9):e04731. PubMed ID: 34484765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Ozone Injection Therapy in Temporomandibular Disorders.
    Haghighat S; Oshaghi S
    Adv Biomed Res; 2020; 9():73. PubMed ID: 33816392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of male genital dysesthesia with botulinum toxin.
    Raef HS; Elmariah SB
    JAAD Case Rep; 2021 Apr; 10():60-62. PubMed ID: 33786355
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin A: a short-term treatment option for base-of-thumb osteoarthritis?
    Døssing A; Bliddal H
    Lancet Rheumatol; 2022 Jul; 4(7):e453-e454. PubMed ID: 38294013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.